scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0003-4975(97)00845-X |
P698 | PubMed publication ID | 9354506 |
P2093 | author name string | S Gupta | |
L Baker | |||
M S Mulligan | |||
J P Lynch | |||
F J Martinez | |||
R I Whyte | |||
S J Rossi | |||
R Florn | |||
P2860 | cites work | Obliterative bronchiolitis after lung and heart-lung transplantation | Q41096367 |
Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation | Q45039146 | ||
RS-61443--a new, potent immunosuppressive agent | Q45300416 | ||
Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials | Q48786548 | ||
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. | Q51048799 | ||
Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation | Q71023240 | ||
Aerosolized cyclosporine in lung recipients with refractory chronic rejection | Q71046268 | ||
Clinical trial of tacrolimus versus cyclosporine in lung transplantation | Q71710715 | ||
Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management | Q71873465 | ||
Bronchiolitis obliterans in single-lung transplant recipients | Q72129884 | ||
Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil | Q72854731 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bronchiolitis | Q424227 |
lung transplant | Q1637912 | ||
P304 | page(s) | 945-948 | |
P577 | publication date | 1997-10-01 | |
P1433 | published in | The Annals of Thoracic Surgery | Q1939819 |
P1476 | title | Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation | |
P478 | volume | 64 |
Q37902258 | A review of bronchiolitis obliterans syndrome and therapeutic strategies |
Q35625678 | Bronchiolitis obliterans |
Q36623201 | Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation |
Q44893166 | Bronchiolitis obliterans syndrome: utility of the new guidelines in single lung transplant recipients |
Q53344804 | Development of obliterative bronchiolitis after allogeneic rat lung transplantation: implication of acute rejection and the time point of treatment. |
Q46421609 | Esophageal Motor Dysfunction and Gastroesophageal Reflux Are Prevalent in Lung Transplant Candidates |
Q33996931 | Immunosuppression for lung transplantation |
Q38240865 | Immunosuppression in lung transplantation |
Q34538559 | Immunosuppression in transplantation. A new millennium in care. |
Q94476118 | Immunosuppressive strategies in lung transplantation |
Q55385759 | Individualizing immunosuppression in lung transplantation. |
Q74842942 | Lung retransplantation in children |
Q34395027 | Lung transplantation for primary pulmonary hypertension |
Q35293950 | Lung transplantation. Bronchiolitis obliterans syndrome |
Q35214723 | Lung transplants with tacrolimus and mycophenolate mofetil: a review |
Q39033218 | Observational Study of Methotrexate in the Treatment of Bronchiolitis Obliterans Syndrome. |
Q34533624 | Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin. |
Q33957200 | The use of mycophenolate mofetil in transplant recipients |
Q44280627 | Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome |
Q35711255 | Use of cyclosporine in thoracic transplantation |
Search more.